Cure Genetics is a biotechnology company established by pioneers in CRISPR technologies in 2016 and based in Suzhou, China. We are committed to developing cutting-edge applications of technologies in innovative medicines and molecular diagnostics, which contribute to the next-generation treatment to cancers and genetic diseases.
Cure Genetics aims to become a platform of genetic engineering and build proprietary technological platform. We have talented scientists from world leading universities, experienced drug development team and high-profile SAB with profound experience in industry, science and clinical practice. With 3000+ ㎡ research center and including 800㎡ GMP plant, we’ve also established partnership with top-class hospitals in clinical research / trials.